Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6‐year survival in patients with chronic liver disease
- 31 January 2006
- journal article
- Published by Wiley in Liver International
- Vol. 26 (2) , 173-181
Abstract
Abstract: Background/Aims: Alterations of plasma coagulation factor XIII may contribute to bleeding disorders in patients with liver cirrhosis. As standard clotting tests such as prothrombin time or activated thromboplastin time (aPTT) cannot detect factor XIII deficiency, this may often be overlooked in clinical practice. We aimed to define factor XIII's clinical and prognostic role in chronic liver disease.Patients and methods: Factor XIII activities were assessed among various other parameters in 111 patients with chronic liver diseases during evaluation for liver transplantation in a prospective study.Results: Unlike coagulation factors II, V or VII, factor XIII activity was maintained in the majority of patients with liver cirrhosis. However, although rarely, factor XIII deficiencies (Conclusions: Factor XIII deficiency is rare in patients with liver cirrhosis, but is associated with a clinical bleeding tendency and an unfavorable prognosis for future hemorrhages and survival.Keywords
This publication has 23 references indexed in Scilit:
- High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivoJournal of Hepatology, 2005
- Decreased Factor XIII Availability for Thrombin and Early Loss of Clot Firmness in Patients with Unexplained Intraoperative BleedingAnesthesia & Analgesia, 2004
- Prophylactic and perioperative replacement therapy for acquired factor XIII deficiencyJournal of Thrombosis and Haemostasis, 2004
- Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver DiseasesHepatology, 2003
- Ghrelin in chronic liver diseaseJournal of Hepatology, 2003
- FACTOR XIII DEFICIENCYBritish Journal of Haematology, 1999
- Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patientsHepatology, 1995
- Hyperfibrinolysis Increases the Risk of Gastrointestinal Hemorrhage in Patients With Advanced CirrhosisHepatology, 1992
- A Contribution to the Pathology of Acquired Plasma Factor XIII DeficiencySeminars in Thrombosis and Hemostasis, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958